Skip to main content
SpringerLink
Log in

Vaskuläre und parenchymatöse Nierenkrankheiten

  • Chapter
Book cover Die ärztliche Begutachtung

  • 1479 Accesses

Auszug

Nach der National Health and Nutrition Examination Survey (NHANES III, Coresh et al. 2001) weisen rund 3% der Gesamtbevölkerung erhöhte Serumkreatininspiegel auf mit > 1,6 mg/dl (>141 μmol/1) bei Männern und > 1,4 mg/dl (>124 μmol/1) bei Frauen. Die Prävalenz der Mikroalbuminurie in der Allgemeinbevölkerung wird mit rund 6% bei Männern und 10% bei Frauen angegeben (Jones et al. 2003). Die Prävalenz der chronischen Nierenersatztherapie in Deutschland beträgt 919 Patienten pro 1 Million Einwohner (Dezember 2001, Frei u. Schober-Halstenberg 2003), davon 695 Patienten pro 1 Million Einwohner mit Dialysetherapie (Hämodialyse plus Peritonealdialyse) und 224 Patienten pro 1 Million Einwohner nach Nierentransplantation. Die Anzahl der Neuerkrankungen lag im Jahr 2001 bei 184 Patienten pro 1 Million Einwohner. Weltweit liegen Inzidenz und Prävalenz in Deutschland (184/919 pmp), zusammen mit Japan (262/1722 pmp) und den USA (337/1321 pmp), relativ hoch.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, for the DASH Collaborative Research Group (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124

    Article  PubMed  CAS  Google Scholar 

  • Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Langer K, Zidek W (1995) Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 6:121–125

    Article  PubMed  CAS  Google Scholar 

  • Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147–152

    Article  PubMed  CAS  Google Scholar 

  • Bellomo R, Atkins RC (1993) Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 63:249–254

    PubMed  CAS  Google Scholar 

  • Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105:1810–1815

    Article  PubMed  CAS  Google Scholar 

  • Bianchi G (2000) Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 15(Suppl 5):105–110

    Article  PubMed  Google Scholar 

  • Black RM (1996) Rose and Black’s clinical problems in nephrology. Little, Brown and Company, Boston

    Google Scholar 

  • Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617

    PubMed  CAS  Google Scholar 

  • Brady HR, Singer GG (1995) Acute renal failure. Lancet 346:1533–1540

    Article  PubMed  CAS  Google Scholar 

  • Bundesministerium für Gesundheit und Soziale Sicherung (Hrsg) (2004) Anhaltspunkte für die ärztliche Gutachtertätigkeit im sozialen Entschädigungsrecht und nach dem Schwerbehindertenrecht

    Google Scholar 

  • Björck S, Mulec H, Johnsen SA, Norden G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304:339–343

    PubMed  Google Scholar 

  • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869

    Google Scholar 

  • Chkhotua AB, Klein T, Shabtai E, Yussim A, Bar N, Shaharabani E, Lustig S, Mor E (2003) Kidney transplantation from living-unrelated donors: Comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Urology 62:1002–1006

    Article  PubMed  Google Scholar 

  • Clarkson TW, Magos L, Myers GJ (2003) The toxicology of mercury — current exposures and clinical manifestations. N Engl J Med 349:1731–1737

    Article  PubMed  CAS  Google Scholar 

  • Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ (2001) Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 161:1207–1216

    Article  PubMed  CAS  Google Scholar 

  • Danovitch GM (1996) Handbook of kidney transplantation. Little, Brown and Company, Boston

    Google Scholar 

  • Davis CL, Delmonico FL (2005) Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 16:2098–2110

    Article  PubMed  Google Scholar 

  • Daugirdas JT, Ing TS (1994) Handbook of dialysis. Little, Brown and Company, Boston

    Google Scholar 

  • Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy in the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 47:1703–1720

    Article  Google Scholar 

  • Dubach UC, Rosner B, Stürmer T (1991) An epidemiologic study of abuse of analgesic drugs. Effect of salicylate on mortality and cardiovascular morbidity. N Engl J Med 324:155–160

    Article  PubMed  CAS  Google Scholar 

  • Floege J, Gröne HJ (2003) IgA-Nephropathie. Internist 44:1131–1139

    Article  PubMed  CAS  Google Scholar 

  • Frei U, Schober-Halstenberg (2003) Nierenersatztherapie in Deutschland. Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2003. QuaSi-Niere 2003

    Google Scholar 

  • Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106:1974–1979

    Article  PubMed  Google Scholar 

  • Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538

    Article  PubMed  CAS  Google Scholar 

  • Huber W, Tewes G (1987) Der chronisch Nierenkranke im Erwerbsleben. In: Konietzko H (Hrsg) Handbuch der Arbeitsmedizin. Ecomed, Landsberg

    Google Scholar 

  • Jenette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337:1512–1523

    Article  Google Scholar 

  • Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B (2002) Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346:913–923

    Article  PubMed  CAS  Google Scholar 

  • Jones CA (2003) Hypertension and renal dysfunction: NHANES III. J Am Soc Nephrol. 14:S71–S75

    Article  PubMed  Google Scholar 

  • Kindler J, Giani G, Handt S, Sieberth HG (1990) Einfluss verschiedener Faktoren auf die Progredienz der Niereninsuffizienz bei Analgetika-Nephropathie. Klin Wochenschr 68:1042–1049

    Article  PubMed  CAS  Google Scholar 

  • Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13–18

    Article  PubMed  CAS  Google Scholar 

  • Konietzko H (1996) Cadmium und seine Verbindungen. In: Konietzko H, Dupus H (Hrsg) Handbuch der Arbeitsmedizin. Ecomed, Landsberg

    Google Scholar 

  • Langford CA (2003) Treatment of ANCA-associated vasculitis. N Engl J Med 349:3–4

    Article  PubMed  Google Scholar 

  • Lewrenz H, Friedel B (1985) Krankheit und Kraftverkehr. Gutachten des gemeinsamen Beirats für Verkehrsmedizin beim Bundesminister für Verkehr und beim Bundesminister für Jugend, Familie und Gesundheit. Schriftenreihe des Bundesministers für Verkehr, Heft 67, Bonn

    Google Scholar 

  • Lin JL, Lin-Tan DT, Hsu KH, Yu CC (2003) Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348:277–286

    Article  PubMed  CAS  Google Scholar 

  • London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME (2001) Arterial wave reflections and survival in end-stage renal failure. Hypertension 38:434–438

    PubMed  CAS  Google Scholar 

  • Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF (1997) Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 8:1921–1929

    PubMed  CAS  Google Scholar 

  • Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939–945

    Article  PubMed  CAS  Google Scholar 

  • Maxwell MH, Fitzsimmons E, Harrist R, Hotchkiss J, Langford HG, Payne GH, Schneider KA, Varaday P (1983) Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants. Hypertension 5: 133–159

    Google Scholar 

  • Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080–1084

    Article  PubMed  CAS  Google Scholar 

  • Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-convertingenzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361:117–124

    Article  PubMed  CAS  Google Scholar 

  • National Kidney Foundation (2001) NKF-K/DOQI Clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64

    Google Scholar 

  • National Kidney Foundation (2003) NKF-K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl4):S1–S201

    Google Scholar 

  • Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338:1202–1211

    Article  PubMed  CAS  Google Scholar 

  • Palmer BF (1995) Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med 43:516–533

    PubMed  CAS  Google Scholar 

  • Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH (1996) The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta-analysis. JAMA 124:627–632

    CAS  Google Scholar 

  • Pontremoli R, Viazzi F, Sofia A, Tomolillo C, Ruello N, Bezante GP, Del Sette M, Martinoli C, Lotti R, Sacchi G, Deferrari G (1997) Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension. Kidney Int 63:S163–S165

    CAS  Google Scholar 

  • Quaschning T, Krane V, Metzger T, Wanner C (2001) Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Am J Kidney Dis 38(Suppl 1):S14–S19

    PubMed  CAS  Google Scholar 

  • Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, Giani G (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189

    PubMed  CAS  Google Scholar 

  • Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 47:2–19

    Article  Google Scholar 

  • Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on longterm ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352:1252–1256

    Article  PubMed  CAS  Google Scholar 

  • Savica V, Costantino G, Monardo P, Bellinghieri G (1995) Subcutaneous low doses of recombinant human erythropoietin in predialysis patients do not interfere with the progression of renal failure. Am J Nephrol 15:10–14

    Article  PubMed  CAS  Google Scholar 

  • Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13:180–193

    Google Scholar 

  • Stehman-Breen C, Wilson R, Alpers CE, Gretch D, Johnson RJ (1995) Hepatits C virus-associated glomerulonephritis. Curr Opinion Nephrol Hypertens 4:287–294

    Article  CAS  Google Scholar 

  • Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W (2003) The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 107: 992–995

    Article  PubMed  CAS  Google Scholar 

  • Wasserstein AG (1997) Membranous glomerulonephritis. J Am Soc Nephrol 8:664–674

    PubMed  CAS  Google Scholar 

  • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145–153

    Article  PubMed  CAS  Google Scholar 

  • Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J, Boger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113–2117

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charité, Campus Benjamin Franklin Medizinische Klinik IV Nephrologie, Hindenburgdamm 30, 12200, Berlin

    Prof. Dr. med. M. Tepel & Prof. Dr. med. W. Zidek

Authors
  1. Prof. Dr. med. M. Tepel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. W. Zidek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität Frankfurt am Main, Deutschland

    Jürgen Fritze

  2. Verband der privaten Krankenversicherung e. V., Bayenthalgürtel 26, 50968, Köln

    Jürgen Fritze

  3. Stabsbereich für Rehabilitationsstrategien und -grundsätze, Deutsche Gesetzliche Unfallversicherung (DGUV), Mittelstraße 51-55, 10117, Berlin

    Friedrich Mehrhoff

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Steinkoff Verlag

About this chapter

Cite this chapter

Tepel, M., Zidek, W. (2008). Vaskuläre und parenchymatöse Nierenkrankheiten. In: Fritze, J., Mehrhoff, F. (eds) Die ärztliche Begutachtung. Steinkopff. https://doi.org/10.1007/978-3-7985-1564-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1564-2_19

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1563-5

  • Online ISBN: 978-3-7985-1564-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation